Our Firm continues to hear from Biomet hip recipients who have suffered serious complications, some of which required revision surgery, allegedly due to the Biomet M2a Magnum hip.
New York, New York (PRWEB) August 17, 2013
Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) continue to mount in the federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an update issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on August 15th, 587 Biomet hip replacement claims involving the M2a Magnum hip are now pending in the proceeding. In its previous update issued on July 10th, the JPML reported that 493 lawsuits had been filed in the Biomet hip litigation. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“Our Firm continues to hear from Biomet hip recipients who have suffered serious complications, some of which required revision surgery, allegedly due to the Biomet M2a Magnum hip,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free and confidential case evaluations to individuals who may have been injured by Biomet hip replacements.
Biomet Hip Replacement Lawsuits
All of the Biomet hip lawsuits pending in the Northern District of Indiana allege that recipients of the M2a Magnum hip suffered serious complications, including metallosis, chronic pain, and premature failure of the hip, due to shedding of toxic metal debris caused by wear of its metal components. Bernstein Liebhard LLP is actively filing claims in the proceeding. The litigation’s next Status Conference has been scheduled for September 23, 2013.
The Biomet hip replacement at the center of this litigation is a metal-on-metal hip implant, in which the ball and cup is constructed of a chromium/cobalt alloy. All-metal hips are the subject of a U.S. Food & Drug Administration (FDA) safety review, due to concerns that the metal debris shed from the devices can lead to bone and tissue damage, pain, implant loosening, and premature device failure. On January 17, 2013, the FDA advised patients with metal-on-metal hip implants to undergo metal ion screening if they were experiencing symptoms of hip failure. The agency also announced that it had proposed new regulations that, if adopted, would subject all-metal implants to greater regulatory scrutiny.
Biomet hip replacement recipients who suffered metallosis, premature device failure, or other complications allegedly due to the Biomet M2a Magnum hip may be entitled to compensation for medical bills, lost wages, pain and suffering and other damages. Read More about Biomet hip lawsuits at Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP